Skip to main content
. 2021 Jun 12;7:292–323. doi: 10.1016/j.bioactmat.2021.05.038

Table 3.

Advantages and disadvantages of different types of nanocarriers in the TOs delivery.

Nanocarriers Advantages Disadvantages
Lipid-based nanoparticles
  • Low cytotoxicity

  • ●Long long-circulating and high bioavailability

  • ●Diversity and scale-up feasibility

  • ●High transfection activity

  • ●May trigger immunogenicity

  • ●Difficult to obtain smaller size

Polymeric nanoparticles
  • ●Versatility of structural design

  • ●Stimuli-responsive drug delivery

  • ●Biodegradable

  • ●Controlled drug release

  • ●Difficult to scale-up

  • ●Low drug loading efficiency

  • ●Stability may be a problem for micellar structures

Gold nanoparticles
  • ●Molecular sensing feasibility based on the localized surface plasmon resonance

  • ●Tunability of size and shape

  • ●Photothermal effect

  • ●Easy surface functionalization

  • ●Non-degradable

  • ●Slow body clearance

  • ●Nanotoxicity

Porous nanomaterials
  • ●Structure homogeneity with large active surface area

  • ●Controllable porosity

  • ●High drug-loading capacity

  • ●Capacity to obtain gated supports for on‐demand TOs delivery

  • ●Stability of dispersion requires careful design of surface chemistry

  • ●Possible nanotoxicity for MOF-based materials

DNA/RNA nanoassembly
  • ●Programmability and predictability in TOs loading

  • ●TOs themselves are also building blocks

  • ●Precise structures with addressable modification sites

  • ●High expenses

  • ●Nuclease degradation

Extracellular Vesicles
  • ●Good biocompatibility and low immunogenicity

  • ●Tumor-homing ability and capacity to cross biological barriers

  • ●Superior delivery efficiency

  • ●Tunable surface receptors for site-specific delivery

  • ●No standard methodologies

  • ●Heterogeneous vesicle structures